Breaking News Instant updates and real-time market news.

ACAD

Acadia

$21.99

0.31 (1.43%)

16:11
11/06/18
11/06
16:11
11/06/18
16:11

Acadia reports Q3 EPS (50c), consensus (58c)

Reports Q3 revenue $58.3M, consensus $56.31M. At September 30, 2018, ACADIA's cash, cash equivalents and investment securities totaled $214.1M, compared to $341.3M at December 31, 2017.

  • 06

    Nov

  • 12

    Nov

ACAD Acadia
$21.99

0.31 (1.43%)

10/16/18
CANT
10/16/18
NO CHANGE
Target $27
CANT
Overweight
Acadia price target raised to $27 from $25 at Cantor Fitzgerald
Cantor Fitzgerald analyst Charles Duncan raised his price target for Acadia Pharmaceuticals to $27 and reiterates an Overweight rating on the shares. Acadia in August announced a licensing agreement with Neuren Pharmaceuticals for Trofinetide in Rett syndrome, Duncan tells investors in a research note. The analyst believes this is an underappreciated asset that could diversify the company's pipeline strategy over the next 12 months. After meeting with Neuren, Duncan has enhanced conviction on Trofinetide and believes that the path forward increases Phase 3 probability of success in the "as-yet untreatable neurodevelopmental disorder."
10/31/18
PIPR
10/31/18
NO CHANGE
PIPR
Overweight
Acadia depression data warrant 15% share upside, says Piper Jaffray
Acadia Pharmaceuticals this morning announced positive results with Nuplazid in major depressive disorder from its Phase 2 trial, Piper Jaffray analyst Danielle Brill tells investors in a research note titled "A Few Tricks, But Mostly Treats for ACAD Today: Data Overall De-Risk MDD Opportunity". Nuplazid demonstrated statistically significant improvements across multiple efficacy endpoints, says the analyst. She interprets the results as an "overall positive given an evident trend of benefit with Nuplazid." While the results aren't a clear "homerun," share upside of around 15% is warranted, Brill contends. She estimates such a move would reflect a 20%-30% risk adjusted major depressive disorder opportunity of $750M. Brill keeps an Overweight rating on Acadia with a $25 price target. The stock in morning trading is down 3%, or 68c, to $20.41.
11/01/18
CANT
11/01/18
NO CHANGE
Target $30
CANT
Overweight
Acadia price target raised to $30 from $27 at Cantor Fitzgerald
Cantor Fitzgerald analyst Charles Duncan raised his price target for Acadia Pharmaceuticals to $30 citing the positive top-line data from the non-zero risk Phase 2 Clarity study of pimavanserin in major depressive disorder. The analyst now believes we now believe pimavanserin use in MDD may prove to be a longer-term revenue driver, especially for high-burden patients and despite emerging/later-stage efforts with glutamate-modulating drugs. He reiterates an Overweight rating on Acadia.
11/01/18
HCWC
11/01/18
NO CHANGE
Target $60
HCWC
Buy
Acadia stage 1 results outweigh stage 2 miss, says H.C. Wainwright
H.C. Wainwright analyst Andrew Fein thinks Acadia Pharmaceuticals' top-line data release yesterday provided supportive evidence for pimavanserin's potential as an adjunctive therapy for major depressive disorder. However, he points out two major concerns from the study that he believes could shape this program's risks. Although the study hit primary endpoint of change in HAMD-17 score from baseline in stage 1 and in combined analysis, there was no significant benefit observed with pimavanserin treatment versus placebo in stage 2 of the study, Fein tells investors in a research note titled "Trick or Treat? Stage 1 Results Outweigh Stage 2 Miss, In Our View." This result naturally raises the question whether the treatment effect was indeed real rather than an artifact, says the analyst. And second, Fein points out that there has not been any drug approved by the FDA using a sequential parallel comparison design. This, he believes, would add to the regulatory risk of the program, given that the Phase 3 trial would be similar in design to the Clarity trial, per management. Fein has a Buy rating on Acadia with a $60 price target.

TODAY'S FREE FLY STORIES

BA

Boeing

$349.62

-7.31 (-2.05%)

05:55
11/14/18
11/14
05:55
11/14/18
05:55
Periodicals
FAA denies report on new investigation of Boeing safety analyses, Reuters says »

The FAA has denied a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LBRDA

Liberty Broadband

$82.52

0.22 (0.27%)

05:55
11/14/18
11/14
05:55
11/14/18
05:55
Conference/Events
Liberty Broadband to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

RGA

Reinsurance Group

$149.53

1.81 (1.23%)

05:55
11/14/18
11/14
05:55
11/14/18
05:55
Conference/Events
Reinsurance Group management to meet with UBS »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

DDAIF

Daimler AG

$0.00

(0.00%)

05:51
11/14/18
11/14
05:51
11/14/18
05:51
Hot Stocks
Daimler to open new R&D center in China to accelerate localization »

Daimler announced plans…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BTI

British American Tobacco

$37.04

-1.04 (-2.73%)

, MO

Altria Group

$60.01

-1.18 (-1.93%)

05:46
11/14/18
11/14
05:46
11/14/18
05:46
Hot Stocks
Juul to halt social media promotions, stop selling most flavors in stores »

Juul Labs said in a…

BTI

British American Tobacco

$37.04

-1.04 (-2.73%)

MO

Altria Group

$60.01

-1.18 (-1.93%)

PM

Philip Morris

$86.42

-1.48 (-1.68%)

FB

Facebook

$142.19

0.67 (0.47%)

SNAP

Snap

$6.72

0.06 (0.90%)

TWTR

Twitter

$32.49

0.49 (1.53%)

GOOG

Alphabet

$1,036.33

-2.89 (-0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 26

    Nov

  • 28

    Nov

  • 03

    Mar

AIBRF

AIB Group

$0.00

(0.00%)

05:44
11/14/18
11/14
05:44
11/14/18
05:44
Upgrade
AIB Group rating change  »

AIB Group upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$192.23

-1.925 (-0.99%)

, LITE

Lumentum

$38.95

1.445 (3.85%)

05:42
11/14/18
11/14
05:42
11/14/18
05:42
Recommendations
Apple, Lumentum, Qorvo analyst commentary  »

UBS drops Apple price…

AAPL

Apple

$192.23

-1.925 (-0.99%)

LITE

Lumentum

$38.95

1.445 (3.85%)

QRVO

Qorvo

$63.68

-0.12 (-0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

AMZN

Amazon.com

$1,631.68

-5.02 (-0.31%)

05:38
11/14/18
11/14
05:38
11/14/18
05:38
Periodicals
Amazon decided to split HQ2 in two in September, WSJ reports »

Amazon officials made the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 28

    Nov

  • 04

    Dec

RMED

Ra Medical Systems

$8.16

-0.455 (-5.28%)

05:33
11/14/18
11/14
05:33
11/14/18
05:33
Recommendations
Ra Medical Systems analyst commentary  »

Piper recommends purchase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

REGN

Regeneron

$342.12

-4.45 (-1.28%)

05:30
11/14/18
11/14
05:30
11/14/18
05:30
Recommendations
Regeneron analyst commentary  »

Regeneron survey…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 27

    Nov

  • 11

    Mar

  • 28

    Apr

  • 13

    May

PAAS

Pan American Silver

$14.13

-0.14 (-0.98%)

, TAHO

Tahoe Resources

$2.20

-0.055 (-2.44%)

05:28
11/14/18
11/14
05:28
11/14/18
05:28
Hot Stocks
Pan American Silver to acquire Tahoe Resources for $3.40 per share »

Pan American Silver…

PAAS

Pan American Silver

$14.13

-0.14 (-0.98%)

TAHO

Tahoe Resources

$2.20

-0.055 (-2.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHVN

Biohaven Pharmaceutical

$36.88

0.46 (1.26%)

05:20
11/14/18
11/14
05:20
11/14/18
05:20
Earnings
Breaking Earnings news story on Biohaven Pharmaceutical »

Biohaven Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 15

    Nov

  • 27

    Nov

BRKR

Bruker

$32.65

-0.21 (-0.64%)

05:19
11/14/18
11/14
05:19
11/14/18
05:19
Hot Stocks
Bruker agrees to acquire Alicona Imaging GmbH, terms not disclosed »

Bruker Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESLT

Elbit Systems

$120.29

-1.45 (-1.19%)

05:18
11/14/18
11/14
05:18
11/14/18
05:18
Hot Stocks
Elbit Systems awarded $167M contract from Asia-Pacific country »

Elbit Systems announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

FTI

TechnipFMC

$23.53

-1.24 (-5.01%)

, CVX

Chevron

$115.35

-2.12 (-1.80%)

05:16
11/14/18
11/14
05:16
11/14/18
05:16
Hot Stocks
TechnipFMC signs surface technologies frame agreement with Chevron »

TechnipFMC (FTI) has…

FTI

TechnipFMC

$23.53

-1.24 (-5.01%)

CVX

Chevron

$115.35

-2.12 (-1.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

05:15
11/14/18
11/14
05:15
11/14/18
05:15
General news
Oil prices erased losses »

Oil prices erased losses…

SERV

ServiceMaster

$43.03

0.545 (1.28%)

05:14
11/14/18
11/14
05:14
11/14/18
05:14
Initiation
ServiceMaster initiated  »

ServiceMaster initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPGI

S&P Global

$180.07

-2.08 (-1.14%)

05:13
11/14/18
11/14
05:13
11/14/18
05:13
Initiation
S&P Global initiated  »

S&P Global initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 03

    Dec

RENN

Renren

$1.53

0.08 (5.52%)

05:13
11/14/18
11/14
05:13
11/14/18
05:13
Hot Stocks
Renren sells SNS business to Beijing Infinities Interactive Media »

Beijing Infinities…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCO

Moody's

$148.05

-2.03 (-1.35%)

05:12
11/14/18
11/14
05:12
11/14/18
05:12
Initiation
Moody's initiated  »

Moody's initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

K

Kellogg

$63.48

-0.81 (-1.26%)

05:08
11/14/18
11/14
05:08
11/14/18
05:08
Downgrade
Kellogg rating change  »

Kellogg downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

WYGPY

WorleyParsons

$0.00

(0.00%)

05:05
11/14/18
11/14
05:05
11/14/18
05:05
Upgrade
WorleyParsons rating change  »

WorleyParsons upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SURRY

Sun Art Retail Group

$0.00

(0.00%)

05:02
11/14/18
11/14
05:02
11/14/18
05:02
Downgrade
Sun Art Retail Group rating change  »

Sun Art Retail Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTT

CatchMark Timber

$9.14

0.045 (0.49%)

04:59
11/14/18
11/14
04:59
11/14/18
04:59
Recommendations
CatchMark Timber analyst commentary  »

CatchMark Timber price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLXN

Flexion

$16.40

0.17 (1.05%)

04:55
11/14/18
11/14
04:55
11/14/18
04:55
Conference/Events
Flexion management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.